22nd Century Group Inc (XXII) Short Interest Update
22nd Century Group Inc (NYSEAMERICAN:XXII) saw a large decline in short interest in the month of December. As of December 29th, there was short interest totalling 7,916,626 shares, a decline of 11.0% from the December 15th total of 8,899,906 shares. Currently, 7.4% of the company’s shares are short sold. Based on an average daily volume of 2,690,529 shares, the days-to-cover ratio is presently 2.9 days.
XXII has been the topic of a number of recent analyst reports. Zacks Investment Research raised 22nd Century Group from a “sell” rating to a “hold” rating in a research note on Tuesday, September 19th. Chardan Capital boosted their price objective on 22nd Century Group from $3.50 to $11.50 and gave the company a “buy” rating in a research note on Monday, October 16th.
22nd Century Group (NYSEAMERICAN:XXII) opened at $3.31 on Thursday. The stock has a market capitalization of $395.41, a PE ratio of -25.46 and a beta of 3.03. 22nd Century Group has a 52 week low of $0.81 and a 52 week high of $3.55.
Hedge funds have recently bought and sold shares of the stock. Steward Partners Investment Advisory LLC acquired a new position in 22nd Century Group during the 3rd quarter worth approximately $100,000. Wells Fargo & Company MN raised its stake in 22nd Century Group by 1,422.2% during the 3rd quarter. Wells Fargo & Company MN now owns 68,500 shares of the biotechnology company’s stock worth $190,000 after buying an additional 64,000 shares during the period. Bristol Advisors LLC acquired a new position in 22nd Century Group during the 3rd quarter worth approximately $201,000. Advisor Group Inc. raised its stake in 22nd Century Group by 49.3% during the 3rd quarter. Advisor Group Inc. now owns 73,775 shares of the biotechnology company’s stock worth $204,000 after buying an additional 24,375 shares during the period. Finally, Bank of New York Mellon Corp raised its stake in 22nd Century Group by 46.7% during the 3rd quarter. Bank of New York Mellon Corp now owns 102,993 shares of the biotechnology company’s stock worth $285,000 after buying an additional 32,773 shares during the period.
TRADEMARK VIOLATION WARNING: This piece of content was first posted by American Banking News and is owned by of American Banking News. If you are accessing this piece of content on another site, it was illegally copied and reposted in violation of U.S. and international trademark and copyright legislation. The correct version of this piece of content can be accessed at https://www.americanbankingnews.com/2018/01/11/22nd-century-group-inc-xxii-short-interest-update-2.html.
About 22nd Century Group
Receive News & Ratings for 22nd Century Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 22nd Century Group and related companies with MarketBeat.com's FREE daily email newsletter.